MBOT
Microbot Medical Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$0.95
+0.29%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$0.95
From 52W high−66.57%
Volume387409.00
Market cap$63.99M
P/E (TTM)—
P/S (TTM)185.0x
Div yield—
Key dataOct 19, 2026
Open
$0.95
From 52W high
−66.57%
Volume
387409.00
Market cap
$63.99M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.2x
P/E (TTM)
—
RSI (14)
21.0
MomentumView details →
1D Return
+0.29%
YTD Return
−51.50%
SummaryUpdated Jun 1, 2026
Microbot Medical Inc. (NASDAQ:MBOT) is a pre-clinical medical device company founded in 2010 and based in Hingham, Massachusetts. The company specializes in developing robotic endoluminal surgery devices for minimally invasive surgical procedures. Since going public in 1992, Microbot has focused on creating innovative micro-robotic technologies for various medical applications, including treatments for hydrocephalus and endovascular interventions. The company maintains a strategic collaboration with Stryker Corporation, a major medical technology company, for technology co-development purposes.
Similar companies
Latest newsMore news →
Microbot Medical and Medtechnica Ltd. entered into a three-year exclusive distribution agreement for the LIBERTY Endovascular Robotic System in Israel.14d agoMicrobot Medical Inc. reported a second-quarter net loss of $0.08 per share, in line with the Zacks Consensus Estimate and narrower than the year-ago loss of $0.10 per share.69d ago